0703山師さん@トレード中 (ワッチョイ 5f8e-Lfn0 [202.124.52.145 [上級国民]])
2018/11/13(火) 23:01:55.25ID:7MDh2N+h0Financial Results for the Three and Nine Months Ended September 30, 2018:
・Revenue: Revenue recognized during the quarter was principally derived from collaboration agreements with Surface Oncology, Merck and Heptares.